Communiqués Ceryvyn Therapeutics Limited

Actions

CYV

AU0000478117

Recherche biotechnologique et médicale

Cours en clôture Australian S.E. 19/08/2026			Varia. 5j.	Varia. 1 janv.
0,0120 ^AUD	+9,09%		+9,09%	-98,00%

03/06	Opthea s'apprête à reprendre sa cotation sur l'ASX après la décision de faire progresser son candidat-médicament contre une pathologie pulmonaire	MT
02/03	Opthea renoue avec les profits au premier semestre fiscal, affiche un chiffre d'affaires en baisse et envisage un changement de nom	MT

Communiqués

15/01	Opthea : Notification of cessation of securities - OPT	PU
22/12	Opthea : Change of Director's Interest Notice - KC & LG	PU
17/12	Opthea : Investor Update Presentation	PU
07/12	Opthea : Change in substantial holding	PU
11/11	Opthea : Results of AGM	PU
15/09/25	Opthea : Annual Report for Fiscal Year Ending June 30, 2025 (Form 20-F)	PU
15/09/25	Opthea : Annual Report 2025	PU
19/08/25	Opthea Provides Corporate Update	AQ
31/03/25	Opthea Announces Decision to Discontinue Wet AMD Trials	AQ
24/03/25	Opthea Announces COAST Phase 3 Trial Topline Results	AQ
03/03/25	Opthea Announces Phase 2b Wet AMD Publication	AQ
28/02/25	Opthea Reports Half Year Results and Business Updates	AQ
26/02/25	Opthea Completes Drug Product PPQ Campaign	AQ
18/02/25	Opthea Completes COAST Final Week 52 Patient Visit	AQ
07/02/25	Opthea to Present at Oppenheimer Healthcare Conference	AQ
06/02/25	Opthea Wet AMD Data Featured at Macula Society Meeting	AQ
08/01/25	Opthea to Host Investor Days in New York and Australia	AQ
07/01/25	Opthea Announces Publication in Diabetic Macular Edema	AQ
19/12/24	Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference	AQ
19/12/24	Opthea : to Present at 43rd Annual J.P. Morgan Healthcare Conference Form 6 K	PU
26/11/24	Opthea’s Wet AMD Program to be Featured at FLORetina 2024	AQ
26/11/24	Opthea : Wet AMD Program to be Featured at FLORetina 2024 Form 6 K	PU
25/11/24	Opthea to Participate in Citi 2024 Global Healthcare Conference	AQ
25/11/24	Opthea : to Participate in Citi 2024 Global Healthcare Conference Form 6 K	PU
18/11/24	Opthea Appoints Kathy Connell to Board of Directors	AQ